Cell-free DNA as a novel marker in cancer therapy

Area of Science:

• Oncology
• Genomics
• Molecular Diagnostics

Background:

• Next-generation sequencing (NGS) advances cancer insights and therapies.
• Precision medicine requires genomic aberration assessment, hindered by intratumoral heterogeneity and real-time tumor analysis challenges.

Purpose of the Study:

• To review recent advances in understanding the clinical utility of cell-free DNA (cfDNA) in cancer management.
• To explore future directions for cfDNA in oncology.

Main Methods:

• Review of recent scientific literature on cell-free DNA detection and analysis in cancer patients.
• Analysis of technological advancements enabling cfDNA assessment.

Main Results:

• Cell-free DNA analysis provides real-time assessment of tumor evolution.
• cfDNA detection and analysis overcome limitations of traditional tumor assessment methods.

Conclusions:

• Cell-free DNA is a promising tool for real-time cancer monitoring and precision medicine.
• Further research into cfDNA clinical utility will shape future cancer management strategies.